Fermented Foods
Two daily servings of fermented dairy — yogurt and the cultured milks — track with modestly lower cardiovascular and all-cause mortality, and traditional natto (fermented soybeans) has the largest single-food effect in the data, from the narrowest evidence base. Sauerkraut and kimchi have no mortality signal behind them; the one cohort that measured the category found nothing. What they have is microbiome and immune data. Fermented bread and most flavored, pasteurized supermarket "ferments" do not behave the same way.
"Fermented foods" is not one category. Kefir, yogurt, sauerkraut, kimchi, natto, miso, and kombucha each pair a different raw substrate with a different microbial community, and the clinical signals differ accordingly. The shared mechanism is microbial transformation of the food matrix into smaller, more bioavailable compounds plus a steady stream of bacterial metabolites and cell-wall fragments that the gut and immune system see daily.
What the evidence says
Strong:
- Habitual fermented-milk intake (yogurt, and the cultured milks generally) tracks with lower all-cause, cardiovascular, and cancer mortality in pooled cohort data — the most consistent epidemiologic signal in the fermented-food literature, though the effect is modest (roughly 6–7% lower risk). Aged cheese is analysed separately and comes out weaker: about 3% lower all-cause mortality, with no association for cardiovascular or cancer death. Kefir has no pooled mortality estimate at all[1].
- Natto (fermented soybeans, Bacillus subtilis var. natto) is the richest dietary source of vitamin K2 (menaquinone-7, MK-7); habitual consumers show higher circulating MK-7, more carboxylated osteocalcin, and modestly higher bone mineral density[2].
- A prospective cohort of elderly Japanese men — 1,548 of them analysed over an average 12 years — found habitual natto intake (several packs per week) associated with about 40% lower all-cause mortality; the separate Takayama cohort ties natto to lower cardiovascular mortality, more strongly than total soy[3], [4].
Moderate:
- Sauerkraut, kimchi, and other vegetable ferments nudge a handful of gut-bacterial species toward short-chain-fatty-acid producers over weeks — but the trials that measured this — one randomized controlled trial (RCT) and one single-arm study — found no matching improvement in inflammatory markers or blood glucose (the crossover measured neither; the athlete study measured both and found no change). The one sauerkraut study that measured inflammation and insulin (single-arm, ten athletes) found nothing (C-reactive protein p = 0.47, insulin p = 0.85), and the largest trial concluded the healthy gut microbiome is "rather resilient to short-term dietary interventions"[5], [6].
- Kefir may modestly improve fasting glucose and insulin markers, but the reviewers' own summary is that "the overall strength of evidence remains limited" — and the one trial that compares kefir against an equal serving of unfermented milk found no significant difference between them in the 22 analysed for that report, too few to rule one out[7], [8]. Mood and cognition claims are weaker still — see the caveat below.
- The fermented food matrix itself — fibre, polyphenols, dead bacterial cell walls, microbial metabolites — appears to do a large share of the work; live colony-forming-unit (CFU) counts at the time of eating are not the dominant variable[9]. The cleanest test of that principle is not a food trial at all: 200 adults with diarrhoea-predominant irritable bowel syndrome were randomised three ways — a live Bifidobacterium longum strain, the identical strain heat-killed, or placebo — and the dead preparation matched the live one almost exactly (industry-funded, with three of the authors employed by the sponsor)[10].
Weak / preliminary:
- Kombucha's glycemic evidence is thinner than its reputation. The systematic review of the field — eight trials, 303 adults — concludes that the beverage showed "minimal effects, including inconsistent findings on glucose metabolism," and that the clinical data "remain inconclusive." The one clean finding is acute: drunk alongside a high-glycemic meal, kombucha measurably blunted that meal's glucose response in healthy young adults[11], [12].
- "Reverses biological age by years" headlines are based on small pilot studies of full lifestyle programs — methyl-donor-rich diet, plant-forward eating, a probiotic supplement, sleep and exercise. Fermented foods were not part of those protocols at all, so the headlines are not fermented-foods evidence in either direction.
- Specific mood-and-cognition ("psychobiotic") effects of dairy versus coconut kefir. A multi-arm pilot in healthy adults exists, but it is not yet peer-reviewed, is unblinded against a no-intervention arm, was registered six years after enrolment began, and has roughly eleven people per arm across about nineteen outcomes[13].
- Activation of the cell's energy-and-stress-sensing longevity pathways by natto compounds. A natto extract does extend adult lifespan in the roundworm Caenorhabditis elegans[14], but the sirtuin and AMP-activated protein kinase (AMPK) attribution is not something any natto paper has tested, there is no rodent lifespan data, and no human trial has tested any of it[15].
Caution:
- Histamine intolerance, mast cell activation syndrome, and active SIBO (small intestinal bacterial overgrowth) — fermented foods are typically high in biogenic amines and rapidly fermentable substrates, and can trigger flares.
- Sodium load — a ¼-cup serving of sauerkraut runs roughly 230–330 mg of sodium and kimchi 175–250 mg, about a tenth of a day's allowance or a little more. Traditional dill pickles are saltier, around 280–400 mg. Miso is in a different class again: one tablespoon carries about 630 mg. If you are watching sodium, the vegetable ferments are not the problem; the miso is the one to count.
- Home fermentation hygiene — the rapid acidification of a healthy ferment is what suppresses pathogens: with 2–2.5% salt by weight the pH begins falling after two to three days and should be below 4.6 — the level below which Clostridium botulinum cannot make toxin — by the end of the first week. A batch that is still unsoured, or has gone slimy or mouldy, at a week should be thrown out[16]. Brine-fermented vegetables are too acidic to be a botulism vehicle, but home fermentation in general is not exempt: in US surveillance, home-prepared foods other than home-canned ones account for the largest single share of foodborne botulism, about a third of it fermented fish and marine mammal. The documented illnesses from fermented vegetables are outbreaks of E. coli O157 carried in on the raw produce. Raw-milk dairy is a separate and larger risk.
Live microbes vs. the food matrix
For decades, the assumption was that fermented foods worked by colonising the gut with their starter cultures. That has not held up. The adult human gut is ecologically resilient, and ingested Lactobacillus species largely transit through rather than settling, and any increase in their numbers appears to be transient[17].
What appears to matter more is the matrix as a whole:
- Microbial metabolites already in the food — short-chain fatty acids, lactic acid, bioactive peptides, microbially liberated polyphenols.
- Dead bacterial cell components ("postbiotics") — peptidoglycans and surface proteins that interact with intestinal innate-immune receptors regardless of whether the cell was alive on arrival.
- Prebiotic structure — the fibre, resistant starch, and complex carbohydrate matrix the food's own microbes have already partially digested, which then feeds the colon's resident bacteria.
The most-cited test of this is a 2025 crossover trial that gave 87 adults 100 g of fresh, live sauerkraut and 100 g of pasteurized sauerkraut for four weeks each. Each arm shifted different individual species — the fresh one a Lacticaseibacillus, the pasteurized one the butyrate producer Anaerostipes hadrus — and only the pasteurized arm raised serum short-chain fatty acids, in the one analysis the trial states it did not correct for multiple testing. The changes looked more pronounced after the pasteurized arm, but the trial never compared its two arms against each other, so "pasteurized beats fresh" is not a result it can deliver. Its own conclusion is that fresh and pasteurized sauerkraut "had no overall impact on the gut microbiota of healthy participants, even though single species changed significantly"[18]. Practical implication: a heat-pasteurized supermarket sauerkraut is not the dead, useless product the live-culture marketing implies, though for variety and additional metabolites a fresh, refrigerated, unpasteurized version is still the better default.
Substrate by substrate
Fermented dairy: yogurt, kefir, traditionally aged cheese
This is the category with the most epidemiologic support, and the effect sizes are now quantifiable. A dose–response meta-analysis of 22 cohorts (579,832 people, 43,118 type 2 diabetes cases) found about 14% lower type 2 diabetes risk at 80 g/day of yogurt versus none (RR 0.86, 95% CI 0.83–0.90)[19]. (Throughout, the bracketed range is the 95% confidence interval — where the true effect most plausibly lies; when it crosses 1.0 the result is compatible with no effect.)
The mortality picture is real but should not be oversold. A 2026 meta-analysis of prospective cohorts found fermented milk associated with roughly 6% lower all-cause mortality, 7% lower cardiovascular mortality, and 6% lower cancer mortality; yogurt specifically tracked with lower all-cause mortality, but its association with cardiovascular death was weaker and did not reach statistical significance[20]. These are the most consistent signals in the fermented-food literature, but they are single-digit relative reductions from observational data, not the dramatic effects the marketing implies. A separate Stanford trial adds a mechanistic thread, with an important caveat: ten weeks of a high-fermented-food diet increased gut-microbiome diversity and lowered 19 of 93 inflammatory signalling proteins, though the trial's pre-registered primary outcome was unchanged in both arms and each arm had only 18 people. The high-fibre arm was not simply inert — it split three ways, with two of the three groups also showing falling inflammatory signalling, and which group a participant landed in tracked with their starting microbiome diversity. Note also the dose: participants ended on about six servings of fermented food a day, roughly triple what this page recommends[21]. Probiotic fermented milk also lowers blood pressure modestly — by about 3.1/1.1 mmHg systolic/diastolic, pooled across 14 RCTs (702 participants)[22]. A pooled analysis of ten Japanese cohorts — 398,690 adults, 69,877 deaths — is a useful corrective: it found no association for yogurt or cheese in either sex, while unfermented milk was protective in men (about 6% lower all-cause mortality, HR 0.94, 95% CI 0.92–0.97). Whether fermentation is doing the work, or dairy is, remains genuinely open[23].
The regulatory state has caught up with the cohorts: on 1 March 2024 the FDA issued its first qualified health claim for yogurt, permitting the statement that eating yogurt at least 2 cups (3 servings) per week "may reduce the risk of type 2 diabetes" — while explicitly noting the evidence is limited. The claim followed a petition by Danone North America, an industry petitioner, and rests on observational rather than trial data, so it confirms the direction of the signal more than its causal strength[24].
Kefir specifically is interesting because it is a more complex symbiotic culture (lactic-acid bacteria + acetic-acid bacteria + yeasts) than yogurt, but the human metabolic data are weaker than often claimed:
- Fasting insulin and insulin resistance (measured as HOMA-IR, the homeostatic-model insulin-resistance index) often fall during kefir trials, but the one randomized trial against an equal serving of unfermented milk, in metabolic syndrome, found no significant difference between them in the 22 analysed for that report — too few to rule one out[25], and pooled trials have since moved: two meta-analyses find kefir cutting the HOMA-IR insulin-resistance index by roughly 2 units, though they disagree with each other about fasting glucose[26], [27]. Neither restricts the comparator to unfermented milk. The honest read: any glycemic benefit is inconsistent and not clearly a fermentation effect rather than a dairy one.
- Cognitive and mood effects (better working memory, lower self-reported stress and anxiety) appear in individual small healthy-adult trials, but the cognitive ones do not survive pooling (the pooled analysis covered cognition, not mood): a meta-analysis of 22 RCTs of prebiotics, probiotics, and fermented foods found no significant effect on global cognition or any cognitive domain — for fermented foods specifically, a small, non-significant improvement (Hedges' g = 0.16, p = 0.08). Many individual studies did report improvements, which the authors attribute to small, short trials and to heterogeneity in the populations and cognitive tests used, rather than to poor study quality: 16 of the 22 trials were at low risk of bias[28]. Treat the mood/cognition story as preliminary.
- Coconut and water kefir are reasonable lactose-free swaps, but nothing supports treating them as equivalent: no trial has compared a non-dairy kefir against a dairy one, and the only human water-kefir study is a 40-person single-arm trial with no comparator[29] — the 2026 systematic review of kefir excluded non-dairy kefir outright[30]. The dairy-specific bioactive peptide chemistry is also absent.
Natto: the largest single-food effect
Natto's reputation rests on three pillars:
- Vitamin K2 (MK-7) — natto delivers an order of magnitude more bioavailable MK-7 than any other commonly eaten food. MK-7 is required to carboxylate osteocalcin (which directs calcium into bone) and matrix Gla-protein (which keeps calcium out of arterial walls). The meta-analytic signal for higher bone mineral density in habitual consumers is real, though modest — a standardised effect of about 0.35 across four Japanese cohort studies once one outlier is excluded. That meta-analysis measured no vascular outcome at all[31]; the calcification half of the argument rests on MK-7 supplement trials, and those are split (see Vitamin K2).
- Nattokinase, a clot-dissolving (fibrinolytic) enzyme produced by B. subtilis var. natto during fermentation. It is genuinely active in laboratory plasma assays, but the one long trial — 265 adults taking 2,000 fibrinolytic units daily for a median three years — found no effect on atherosclerosis progression or on any laboratory measure. Treat it as interesting chemistry rather than a demonstrated cardiovascular benefit[32].
- Cohort mortality data — A cohort of 1,548 elderly Japanese men followed for a mean 12 years found that eating natto several packs per week was associated with about 40% lower all-cause mortality (HR 0.60); at the very highest intake (a pack a day or more) the association weakened and was no longer statistically significant, so the signal sits at moderate rather than maximal intake[33]. The separate Takayama cohort (29,079 adults, 16-year follow-up) links natto specifically to cardiovascular death: highest- versus lowest-quartile intake carried about 25% lower cardiovascular mortality (HR 0.75) and roughly a third lower stroke mortality (HR 0.68). Total soy protein and isoflavones showed no association with cardiovascular death overall — but for stroke specifically, total soy protein was significant too, at about 25% lower stroke mortality (HR 0.75, 95% CI 0.57–0.99), so the natto effect is larger than the generic soy effect rather than separate from it[34].
The taste and smell are an acquired preference. For non-Japanese eaters who don't tolerate it, the practical workaround is a daily MK-7 supplement (90–180 µg), which covers the vitamin K2 but not the nattokinase or peptide effects. The hard-outcome evidence for MK-7 itself is split. See Vitamin K2.
Kimchi: early immune signals and a gastric-cancer caveat
Kimchi is the substrate where the immunology data has caught up with the gastronomy. A 12-week double-blind trial (NCT05898802) in 90 overweight adults used single-cell RNA sequencing on immune cells from the blood of thirteen of them — four or five per arm — eating fermented kimchi powder or a placebo. The kimchi powder upregulated antigen-presenting cell function and pushed helper T-cell (CD4+) differentiation toward both effector and regulatory phenotypes — increased both defensive readiness and anti-inflammatory restraint, without the broad inflammatory activation that synthetic immune-boosters tend to produce[35].
Useful interpretation: this is suggestive evidence that fermented cabbage talks to the immune system in a structured rather than random way. Hold it loosely. The immune analysis was an exploratory add-on to a 90-person trial, covering just thirteen of those people — four to five per arm — and the intervention was 3 g/day of freeze-dried kimchi powder in capsules, not kimchi eaten as a food. It is not evidence that kimchi prevents specific diseases — that step has not been taken in trials.
The harder caveat is gastric cancer, and it deserves to be stated plainly rather than buried. A meta-analysis of prospective cohorts found gastric-cancer risk rising in dose-dependent fashion with pickled-vegetable intake — about 15% higher risk per 40 g/day increment (RR 1.15, 95% CI 1.07–1.23) — driven by the salt load plus nitrates and nitrites that form carcinogenic N-nitroso compounds[36]. This is the East Asian salt paradox: the same traditional ferments linked to metabolic benefit at moderate intake carry a cancer signal at the high end. The benefit appears concentrated at moderate intake. A large cross-sectional analysis (115,726 Korean adults) found 1–3 servings/day associated with roughly 10–12% lower obesity prevalence in men, on a J-shaped curve with the highest intakes trending back the wrong way — though the trend test across intake levels was not itself significant in men. In women, who were two-thirds of the sample, total kimchi intake showed no association at any level and the trend ran mildly upward[37]. Korean adults average about 128 g of kimchi per day, against roughly 11 g/day of pickled vegetables in Japan — the harm signal shows most clearly at very high habitual intake; moderate daily servings have not been shown to be harmful, though the pooled dose-response is a straight-line rise with no safe threshold established. Consistent with that, the Korean prospective cohorts inside the same analysis showed no dose-response for gastric cancer at all, because even their lowest-intake group already eats more than most other populations' highest[38].
Kombucha: thin glycemic data, a fibre-dependent microbiome effect
Kombucha — sweetened tea fermented by a yeast/acetic-acid-bacteria consortium — has the most-discussed glycemic data of any fermented beverage, and it is thinner than its reputation:
- A randomized double-blind crossover pilot in adults with type 2 diabetes drinking 240 mL/day for four weeks reported fasting blood glucose falling from about 164 to 116 mg/dL within the kombucha arm. That figure is widely quoted and should not be: the trial's own comparison of kombucha against placebo was not significant (p = 0.27), and the glucose analysis rests on the seven participants who completed, with glucose self-measured at home[39].
- Kombucha drunk with a high-glycemic-index meal (one that raises blood glucose sharply) lowers the subsequent glucose excursion — the meal's glycemic index fell from 86 to 68 (p = 0.04) when 11 healthy young adults drank 330 mL alongside it. One acute test, in people without diabetes, and one co-author part-owns a kombucha company[40].
- A 6-week 2025 trial of inulin-enriched kombucha in healthy adults increased Bifidobacterium, reduced the mucin-degrading Ruminococcus torques, and nudged triglycerides down — though triglycerides started in the normal range in both groups and the within-group change fell just short of significance[41].
The watch-outs: many commercial kombuchas are back-sweetened enough to negate the point — compositional surveys cluster around 2–8 g of sugar per 250 mL serving, with flavoured products at the top of that range — or pasteurized, which kills the live consortium but, per the sauerkraut data, doesn't necessarily kill the matrix benefit. Read the label and pick the low-sugar versions. Kombucha is also mildly alcoholic — US regulators treat it as an alcoholic beverage if it reaches 0.5% alcohol by volume (ABV) "at any time during production, when bottled, or at any time after bottling", and the regulator explicitly flags continued in-bottle fermentation as a way of crossing that line[42]. Commercial product is meant to stay below it, though a batch used in one clinical trial measured 1.5%[43]. Worth knowing in pregnancy, alcohol-avoidance, or recovery.
Sauerkraut and other vegetable ferments
The 2025 sauerkraut crossover trial above is the most important recent finding for this category: over four weeks both the live and the pasteurized version nudged a handful of individual species, a butyrate producer among them, so the culture being alive was not a precondition for an effect[44]. The honest caveat from that same trial is that a healthy adult's gut microbiome is fairly resilient to a four-week intervention: the changes were real but limited to individual species, not a wholesale remodeling. Nor is there a mortality signal to fall back on: the one cohort to analyse fermented-food intake by subtype, 34,409 Dutch adults over 15 years, found no mortality association for the category as a whole (all-cause HR 1.00, 95% CI 0.88–1.13)[45]. One further study, in ten athletes eating 250 g/day of pasteurized sauerkraut for ten days, saw a similar modest shift — though it was single-arm with no control group, so it corroborates rather than replicates[46].
Traditional salt-fermented cabbage (fermented in brine without vinegar) is the same product. Industrial supermarket "kraut" pickled in vinegar is not — it never went through lactic-acid fermentation, so it has none of the bacterial metabolites, which is a different objection from whether the cultures are still alive.
What's not in the data
- Sourdough bread does not show the mortality signal of fermented dairy or natto in the cohort data — the pooled analysis reports no significant association for bread, though it had only two studies to work with and none isolated sourdough specifically[47]. Baking kills the live culture outright, and the metabolite payload is small relative to a ferment eaten as-is. Sourdough is good bread, but it is not a "longevity food."
- Generic flavored, pasteurized supermarket products marketed as fermented (mass-market kombucha, sweetened "probiotic" yogurts, vinegar-pickled vegetables) do not necessarily inherit the benefits of their traditional counterparts. Sugar content and processing matter.
- Probiotic capsules are a separate category. Most of the fermented-food evidence is about a daily, food-form delivery of microbes, metabolites, and substrate together — not about the colony-forming-unit number on the label.
How to actually use them
Standardized servings
Stanford's nutrition-studies group publishes a working guide to what counts as a serving, noting that there are no official guidelines and no scientific consensus yet. Its definitions are volume-based; the gram equivalents and the natto row below are added here for convenience and are not part of the original[48]:
| Category | One serving |
|---|---|
| Fermented vegetables (sauerkraut, kimchi, traditional pickles) | ¼ cup, ~35–50 g |
| Yogurt, cottage cheese, kefir | ~175 mL (6 fl oz) |
| Kombucha, water kefir | ~175 mL (6 fl oz) |
| Miso | 1 tbsp (~17 g) |
| Fermented salsa | 2 tbsp (~30 g) |
| Vinegar (raw) | 1 tbsp (~15 g) |
| Natto | ~40 g (one standard pack) |
Two servings a day, varied across categories is a reasonable starting target — it is the floor Stanford's guide suggests ("at least 2 servings per day and more as tolerated"), not a ceiling[49]. Worth knowing that the Stanford trial cited above escalated participants to about six servings a day, so two is a starting point rather than a demonstrated optimum.
Adapt slowly
Going from a low-fibre, low-fermented-food baseline to two servings a day overnight can produce bloating, gas, and altered bowel habit for the first week, though tolerance varies more than the advice implies — one crossover trial started 87 adults on 100 g of sauerkraut a day with no ramp-up at all and reported 90–95% contentment and no change in stool form or frequency[50]. The colonic microbiota needs time to upregulate the carbohydrate-active enzymes that break down novel substrates. A gradual build-up is a sensible rule of thumb: start at ~50 g sauerkraut or 50 mL kefir, build over 7–14 days, then layer in a second category.
Pair with fibre
Fermented foods are a delivery vehicle for microbes and metabolites. The benefit ceiling is set by what the resident gut microbiota has to eat. Keep the everyday diet rich in vegetables, legumes, whole grains, and fruit; fermented foods amplify a fibre-rich pattern more than they substitute for one. A Madrid trial is suggestive rather than clean: a kombucha carrying about 10 g of inulin per serving raised Bifidobacterium over six weeks and produced a small triglyceride difference, though both groups started in the normal range and the change within the kombucha arm just missed significance. Because the comparison drink was plain unfermented tea, the trial cannot separate what the fibre did from what the kombucha did — but it is consistent with the general point that ferments work better alongside a substrate the resident bacteria can use[51].
Daily, not occasional
The species a fermented food adds disappear again within a few weeks of stopping. There is no "course of treatment" — fermented foods work to the extent they are part of the everyday diet[52].
Who should be cautious
- Histamine intolerance, mast cell activation syndrome (MCAS) — measured histamine varies far more within a food than between foods, so ranking whole categories is unreliable. Fermented soy averages about 74 mg/kg and aged cheese about 33 mg/kg but reaches 390; sauerkraut averages about 44 mg/kg on a range of 7–80, so a ¼-cup serving carries roughly 2 mg on average and up to about 4 mg[53]. Yogurt is essentially histamine-free and kombucha has not been measured. If you react, work out which foods and which batches rather than cutting the category.
- Anyone taking a classic monoamine-oxidase inhibitor (MAOI) — phenelzine, tranylcypromine, isocarboxazid, or high-dose selegiline. On these drugs tyramine can raise blood pressure sharply, and the ferments carrying the most of it are aged cheese, fermented soy, and fermented sausage and fish. Modern food production has cut tyramine in most foods, so the restriction is narrower than the old diet sheets imply — but it is the one interaction on this page worth clearing with a prescriber rather than self-managing[54].
- Active SIBO or a severe irritable-bowel-syndrome bloating phenotype — symptom-trial; some patients tolerate yogurt and miso while reacting to kombucha and sauerkraut.
- Hypertensive adults with poorly controlled blood pressure — count the sodium in vegetable ferments and miso.
- Immunocompromised patients — the documented risk is specific: soft cheese made from unpasteurised milk carries a per-serving listeriosis risk 50 to 160 times that of the pasteurised equivalent[55]. Vegetable ferments carry the ordinary raw-produce risk rather than a dairy-scale one, and the bloodstream and fungal infections reported in this group come mostly from concentrated probiotic supplements rather than from food. Check with the treating team.
- Anyone taking an anticoagulant or antiplatelet drug (warfarin, a direct oral anticoagulant, aspirin, clopidogrel) — natto is a problem on two counts. Nattokinase is fibrinolytic, and no trial has tested it alongside an anticoagulant or antiplatelet drug, so the combination is untested rather than shown safe. Natto is also by a wide margin the richest food source of vitamin K2, which directly opposes warfarin and the other vitamin-K-antagonist drugs — the newer direct oral anticoagulants are not expected to be affected, but the fibrinolytic question still applies to them. Raise it with your prescriber before making natto a daily habit. See Vitamin K2.
What's overhyped
- "Reverses biological age by years" — the headline traces to one 8-week pilot in 43 men aged 50–72, of whom 38 were analysed, that reported a 3.2-year difference on a DNA-methylation clock[56], and a separate uncontrolled case series of six women that reported an average 4.6-year reduction[57]. Neither protocol contained any fermented food. The pilot has since carried two published corrections, and the clock it used varies by around three years between repeat measurements of the same sample — roughly the size of the effect being claimed.
- High CFU counts on labels — colony-forming units survive stomach acid poorly, and the matrix-and-metabolite story above means even a "10 billion CFU" product is doing most of its work via dead-cell components and prebiotic structure, not live colonies.
- Ginger bug, jun, and other artisanal home-brews as probiotic elixirs — sequencing of homebrewed ginger beer barely exists — two indexed studies worldwide — and the only survey of a home batch found it dominated by environmental bacteria of unknown human relevance rather than by Lactobacillus or Bifidobacterium. The drinks are fine; the probiotic claim is not.
- Probiotic-fortified ultra-processed foods ("probiotic" cereals, gummies, snack bars). The processing destroys the matrix benefit; the food is ultra-processed first and fermented as a marketing layer. See ultra-processed food.
Further reading
- Matalas A, et al. Fermented foods consumption, all-cause, and cause-specific mortality: a meta-analysis of prospective cohort studies. Front Nutr 2026.[58]
- Wastyk HC, Fragiadakis GK, Perelman D, et al. Gut-microbiota-targeted diets modulate human immune status. Cell 2021.[59]
- Gijsbers L, Ding EL, Malik VS, et al. Consumption of dairy foods and diabetes incidence: a dose-response meta-analysis of observational studies. Am J Clin Nutr 2016.[60]
- US FDA. Qualified health claim for yogurt and reduced risk of type 2 diabetes. 2024.[61]
- Nagata C, Wada K, Tamura T, et al. Dietary soy and natto intake and cardiovascular disease mortality in Japanese adults: the Takayama study. Am J Clin Nutr 2017.[62]
- Dong JY, Szeto IMY, Makinen K, et al. Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr 2013.[63]
- Yoo JY, Cho HJ, Moon S, et al. Pickled vegetable and salted fish intake and the risk of gastric cancer. Cancers 2020.[64]
- Jung H, Yun Y-R, Hong SW, Shin S. Association between kimchi consumption and obesity in Korean adults (Health Examinees study). BMJ Open 2024.[65]
- Marx W, Scholey A, Firth J, et al. Prebiotics, probiotics, fermented foods and cognitive outcomes: a meta-analysis of RCTs. Neurosci Biobehav Rev 2020.[66]
- Wen Z, et al. Habitual natto intake, MK-7, osteocalcin carboxylation, and bone density. Meta-analysis. Front Nutr 2025.[67]
- Fujita Y, Kouda K, Tamaki J, et al. A 15-year cohort study of self-reported fermented soybean (natto) intake and all-cause mortality in elderly men. Clin Nutr ESPEN 2025.[68]
- Schropp N, et al. Regular sauerkraut consumption and the human gut microbiota: a crossover intervention trial. Microbiome 2025.[69]
- Lee W, et al. Kimchi dietary intervention modulates antigen-presenting and CD4+ T cells (single-cell RNA-seq, NCT05898802). 2025.[70]
- Fijan S, Povalej Bržan P, Šikić Pogačar M, Klanjšek P. Kefir consumption and health effects based on human clinical trials: an overview of literature. Healthcare (Basel) 2026.[71]
- Bellikci-Koyu E, Sarer-Yurekli BP, Akyon Y, et al. Effects of regular kefir consumption on gut microbiota in patients with metabolic syndrome: a parallel-group, randomized, controlled study. Nutrients 2019.[72]
- Yahyapoor F, et al. Effects of Kefir Consumption on Cardiometabolic Risk Factors: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Curr Drug Targets 2023.[73]
- Praagman J, et al. The relationship between fermented food intake and mortality risk in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort. Br J Nutr 2015.[74]
- Mendelson C, Sparkes S, Merenstein DJ, et al. Kombucha tea as an anti-hyperglycemic agent in humans with diabetes — a randomized controlled pilot investigation. Front Nutr 2023.[75]
- Fraiz GM, et al. Benefits of kombucha consumption: systematic review of clinical trials on microbiota and metabolic health. Fermentation 2025.[76]
- Arce-López B, et al. Fiber-modified kombucha and the gut microbiome: an RCT in healthy adults. Curr Res Food Sci 2025.[77]
- Leeuwendaal NK, et al. Fermented foods, health, and the gut microbiome. Nutrients 2022.[78]
- What counts as a serving of fermented foods? — Stanford Medicine clinical-nutrition guidance.[79]